John Adam Zangerle
Known title: Sr. VP, Gen Counsel, and Sec.CIK: 0001578804
Associated companies
Transaction History
| STE | ▼ Sell | Open Market | 1,419 | $297K | 6/15/2026 | View on chart |
| STE | ▼ Sell | Tax Withholding | 401 | $85K | 6/4/2026 | View on chart |
| STE | ▼ Sell | Tax Withholding | 365 | $77K | 6/3/2026 | View on chart |
| STE | ▲ Buy | Grant | 4,359 | $0 | 6/2/2026 | View on chart |
| STE | ▼ Sell | Tax Withholding | 247 | $52K | 6/2/2026 | View on chart |
| STE | ▼ Sell | Tax Withholding | 337 | $0 | 6/1/2026 | View on chart |
| STE | ▲ Buy | Option Exercise | 15,000 | $1.0M | 11/11/2025 | View on chart |
| STE | ▼ Sell | Open Market | 15,000 | $4.0M | 11/11/2025 | View on chart |
| STE | ▼ Sell | Tax Withholding | 91 | $0 | 10/1/2025 | View on chart |
| STE | ▼ Sell | Open Market | 330 | $79K | 6/13/2025 | View on chart |
| STE | ▼ Sell | Open Market | 1,648 | $398K | 6/13/2025 | View on chart |
| STE | ▼ Sell | Tax Withholding | 425 | $103K | 6/4/2025 | View on chart |
| STE | ▲ Buy | Grant | 3,756 | $0 | 6/3/2025 | View on chart |
| STE | ▼ Sell | Tax Withholding | 346 | $84K | 6/2/2025 | View on chart |
| STE | ▼ Sell | Tax Withholding | 245 | $59K | 6/2/2025 | View on chart |
| STE | ▼ Sell | Tax Withholding | 253 | $61K | 6/2/2025 | View on chart |
| STE | ▼ Sell | Tax Withholding | 91 | $21K | 10/1/2024 | View on chart |
| STE | ▲ Buy | Grant | 4,128 | $0 | 6/4/2024 | View on chart |
| STE | ▼ Sell | Tax Withholding | 245 | $56K | 6/3/2024 | View on chart |
| STE | ▼ Sell | Tax Withholding | 253 | $58K | 6/3/2024 | View on chart |
| STE | ▼ Sell | Tax Withholding | 225 | $51K | 6/3/2024 | View on chart |
| STE | ▼ Sell | Tax Withholding | 346 | $77K | 5/31/2024 | View on chart |
| STE | ▼ Sell | Tax Withholding | 61 | $13K | 10/2/2023 | View on chart |
| STE | ▼ Sell | Tax Withholding | 498 | $102K | 6/2/2023 | View on chart |
| STE | ▼ Sell | Tax Withholding | 225 | $46K | 6/1/2023 | View on chart |
| STE | ▼ Sell | Tax Withholding | 249 | $50K | 5/31/2023 | View on chart |
| STE | ▲ Buy | Grant | 3,471 | $0 | 5/31/2023 | View on chart |
| STE | ▼ Sell | Tax Withholding | 91 | $15K | 10/3/2022 | View on chart |
| STE | ▼ Sell | Open Market | 2,659 | $546K | 6/15/2022 | View on chart |
| STE | ▼ Sell | Tax Withholding | 368 | $84K | 6/2/2022 | View on chart |
| STE | ▲ Buy | Grant | 3,384 | $0 | 6/2/2022 | View on chart |
| STE | ▼ Sell | Tax Withholding | 675 | $149K | 6/1/2022 | View on chart |
| STE | ▼ Sell | Tax Withholding | 2,769 | $632K | 5/31/2022 | View on chart |
| STE | ▲ Buy | Option Exercise | 8,000 | $544K | 4/20/2022 | View on chart |
| STE | ▼ Sell | Open Market | 8,000 | $2.0M | 4/20/2022 | View on chart |
| STE | ▲ Buy | Grant | 808 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
STERIS (STE) to acquire Xodus Medical for $2.1B
STERIS announced a definitive agreement to acquire Xodus Medical for about $2.1 billion. The deal adds a specialty surgical products business focused on patient and operating‑room staff safety, expanding STE’s consumables portfolio. The acquisition aligns with the company’s strategy to grow its healthcare offerings.
STERIS (STE) to acquire Xodus Medical for $2.1B. STERIS announced a definitive agreement to acquire Xodus Medical for about $2.1 billion. The deal adds a specialty surgical products business focused on patient and operating‑room staff safety, expanding STE’s consumables portfolio. The acquisition aligns with the company’s strategy to grow its healthcare offerings.